Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FX33Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,144
Award facts
- Contract value 100% obligated
- $1,143.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a ceiling value of $1,143.89. This competitive award, with no set-aside designation, is issued under a firm fixed-price delivery order contract type and is scheduled for completion by August 21, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. As the prime contractor under the DLA Troop Support Medical IDC, the company provides a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Zepbound, a GLP-1 receptor agonist used for weight management, represents one of many specialty medications within AmerisourceBergen's extensive federal contract portfolio, demonstrating the company's capability to fulfill specialized pharmaceutical requirements for the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FX33Y?
SPE2DB25FX33Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FX33Y worth?
The government has obligated $1,144 on SPE2DB25FX33Y.
Is contract SPE2DB25FX33Y an order under another contract?
Yes. SPE2DB25FX33Y is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX33Y competed?
The extent of competition for SPE2DB25FX33Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award